Karl Hård
Investor Relations Contact chez EGETIS THERAPEUTICS AB
Postes actifs de Karl Hård
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| EGETIS THERAPEUTICS AB | Investor Relations Contact | 01/02/2022 | - |
| Public Communications Contact | 01/02/2022 | - |
Historique de carrière de Karl Hård
Anciens postes connus de Karl Hård
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| KIADIS PHARMA N.V. | Investor Relations Contact | 05/09/2017 | 31/12/2018 |
| Public Communications Contact | 05/09/2017 | 31/12/2018 | |
| REDX PHARMA PLC | Investor Relations Contact | 08/09/2016 | 02/07/2017 |
| Public Communications Contact | 08/09/2016 | 02/07/2017 | |
| University of Leiden | Corporate Officer/Principal | - | - |
| ASTRAZENECA PLC | Public Communications Contact | - | - |
Formation de Karl Hård
| University of Utrecht | Doctorate Degree |
| University of Helsinki | Graduate Degree |
Statistiques
Internationale
| Pays-Bas | 4 |
| Royaume-Uni | 3 |
| Finlande | 2 |
Opérationnelle
| Public Communications Contact | 4 |
| Investor Relations Contact | 3 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| REDX PHARMA PLC | Health Technology |
| EGETIS THERAPEUTICS AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
Kiadis Pharma NV
 Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Kiadis Pharma NV engages in pharmaceutical development of cell-based immunotherapy products in the field of diseases of the blood building system. Its lead product is the ATIR101. The company was founded in 1997 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
